FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35917611000001104: Theophylline 175mg modified-release tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110970901000001117 Theophylline 175mg modified-release tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110971001000001114 Theophylline 175mg modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Theophylline 175mg modified-release tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tabletmodified-release.oral ontology form and route true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Is a Theophylline true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Is a Product containing theophylline false Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Has active ingredient Theophylline false Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Has specific active ingredient Theophylline true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Nuelin SA 175mg tablets (Mawdsley-Brooks & Company Ltd) Is a True Theophylline 175mg modified-release tablets Inferred relationship Existential restriction modifier
Nuelin SA 175mg tablets (Viatris UK Healthcare Ltd) Is a True Theophylline 175mg modified-release tablets Inferred relationship Existential restriction modifier
Theophylline 175mg modified-release tablets 60 tablet Has VMP True Theophylline 175mg modified-release tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start